Short answer · Medically reviewed summary · Last updated: 2026-04-07
Cryopyrin-associated periodic syndrome (CAPS) is a group of rare autoinflammatory disorders caused by gain-of-function mutations in the NLRP3 gene, which leads to the overproduction of the inflammatory protein interleukin-1 beta (IL-1β). These genetic mutations cause the body’s innate immune system to trigger inflammatory responses even in the absence of an infection or external threat. What is the underlying genetic cause of Cryopyrin-associated periodic syndrome? The primary cause of Cryopyrin-associated periodic syndrome is a mutation in the NLRP3 gene, located on chromosome 1.
Cryopyrin-associated periodic syndrome (CAPS) is a group of rare autoinflammatory disorders caused by gain-of-function mutations in the NLRP3 gene, which leads to the overproduction of the inflammatory protein interleukin-1 beta (IL-1β). These genetic mutations cause the body’s innate immune system to trigger inflammatory responses even in the absence of an infection or external threat.
The primary cause of Cryopyrin-associated periodic syndrome is a mutation in the NLRP3 gene, located on chromosome 1. This gene provides instructions for creating a protein called cryopyrin, which is a critical component of the "inflammasome"—a complex inside cells that acts like a security alarm system. In patients with Cryopyrin-associated periodic syndrome, the mutated cryopyrin protein is hyperactive. Think of it like a faulty smoke detector that triggers the fire sprinklers even when there is no fire. This leads to the continuous release of interleukin-1 beta, a potent inflammatory messenger that causes the fever, skin rashes, and joint pain characteristic of the condition.
Cryopyrin-associated periodic syndrome follows an autosomal dominant inheritance pattern. This means that a person only needs to inherit one copy of the mutated NLRP3 gene from one affected parent to develop the condition. However, it is important to note that a significant portion of cases are caused by "de novo" mutations, meaning the genetic change occurs spontaneously in the individual and is not inherited from either parent. In some instances, patients may also exhibit "somatic mosaicism," where the mutation is present in only a fraction of the body’s cells, which can sometimes lead to milder or atypical presentations of Cryopyrin-associated periodic syndrome.
While the root cause of Cryopyrin-associated periodic syndrome is genetic, environmental factors can act as triggers for symptom flare-ups. Patients often report that the following factors exacerbate their condition:
While the link between NLRP3 mutations and the overproduction of IL-1β is well-established, medical research continues to explore why the severity of Cryopyrin-associated periodic syndrome varies so significantly between individuals, even those with the same mutation. Researchers are currently investigating how epigenetic factors and other modifier genes might influence the clinical expression of the disease. At DiseaseMaps.org, 32 people with Cryopyrin-associated periodic syndrome have joined our community, helping researchers better understand the diverse ways this condition manifests across different populations.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with your healthcare provider regarding your specific medical condition.